A Home Telemonitoring System for Wearable Fetal-ECG and EHG Acquisition During Pregnancy
AHTSWFEADP
Flexible Wearable Device for Continuous Fetal Heart Rate and Movement Monitoring.
2 other identifiers
observational
4
1 country
1
Brief Summary
The goal of this observational is to compare in describing fetal health conditions. The main questions it aims to answer are:
- fetal electrocardiogram (fetal heart rate and fetal rhythm)
- electrohysterography (uterine contractions). Participants will wear wearable devices and CTG equipment for monitoring for 30 minutes.If there is a comparison group: Researchers will compare clinical CTG equipment to see if this wearable device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 29, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 6, 2023
CompletedFirst Submitted
Initial submission to the registry
August 29, 2023
CompletedFirst Posted
Study publicly available on registry
September 11, 2023
CompletedSeptember 11, 2023
September 1, 2023
2 months
August 29, 2023
September 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The performance of this system in extracting fetal electrocardiogram (FECG)
extract fetal QRS intervals and numbers from FECG
2022.01-2023.08
The performance of this system in extracting electrohysterography (EHG)
use the contractions consistency index (CCI) parameters to analyze the relation between our measured EHG signal and the UC signal recorded by clinical CTG equipment.
2022.01-2023.08
Interventions
We used wearable devices and clinical cardiotocography (CTG) equipment to monitor pregnant women for 30 minutes to demonstrate the reliability of wearable devices.
Eligibility Criteria
A wearable and remote fetal monitoring system is specifically developed for home use. It aims to overcome the limitations of conventional cardiotocography (CTG) devices by providing great user comfort and long-term continuous monitoring.
You may qualify if:
- Pregnant women with a gestational cycle greater than 36 weeks
You may not qualify if:
- male
- Pregnant women with a gestational cycle less than 36 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fudan Universitylead
Study Sites (1)
FetaCare
Shanghai, Pudong New District, Shanghai, 200100, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tingting Li, master
Fudan University
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- PROSPECTIVE
- Target Duration
- 4 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 29, 2023
First Posted
September 11, 2023
Study Start
May 29, 2023
Primary Completion
July 29, 2023
Study Completion
August 6, 2023
Last Updated
September 11, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share